October 2022 - Page 21 of 22

TuesdayOct 04, 2022 10:30 am

Flora Growth Corp. (NASDAQ: FLGC) Expands Global Distribution Network to Three Industry-Leading Countries; Wins Award for Best M&A Deal at the 2022 Benzinga Cannabis Capital Conference

Flora just announced the first successful export of Colombian high-CBD dried cannabis flower to Switzerland and the Czech Republic, as well as CBD isolate to the United States Luis Merchan, the company’s CEO, has described this as a “major milestone,” one that further defines the company’s revenue pipeline He pointed out the increasing demand for Flora’s high-quality, high-margin flower and derivatives from its cultivation operation in Colombia, terming it as a testament to the Flora team’s ability to execute in a very complex global regulatory environment Flora also earned the Best M&A Deal award at Benzinga’s 2022 Cannabis Capital Conference…

TuesdayOct 04, 2022 9:45 am

Sugarmade Inc. (SGMD) Positioning Itself in Space Seeing Growing Government Support

More than a dozen cannabis reform bills were passed by the California legislature during the summer Governor Newsom signed 10 of the bills SGMD is focused on strengthening its presence in a variety of spaces, including cannabis As the California legislature ended its session last month, more than a dozen cannabis reform bills were approved and sent to Governor Gavin Newsom for his consideration (https://ibn.fm/TLbMU); ultimately, the governor signed 10 of them (https://ibn.fm/HOL7u). The show of government support for cannabis in the state bodes well for California cannabis companies, including Sugarmade (OTC: SGMD), a product and branding marketing company investing…

TuesdayOct 04, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Building on Safety Profile of Concussion Pharmaceutical Treatment, PRV-002, in its Phase I MAD Clinical Trial

Odyssey successfully completed the second Cohort of its Phase I MAD clinical trial, proving the safety profile of its concussion pharmaceutical treatment, PRV-002 This study built on the success of Cohort I, where the drug was well tolerated and proved safe, with no severe adverse events reported The company’s Phase I Single Ascending Dose (“SAD”) cohorts of the clinical trial closed on July 12, 2022, proving the drug was safe and well tolerated. Results from this study were well received by the SRC, who also expressed their optimism for Odyssey’s completion of the MAD portion of its Phase I trial…

MondayOct 03, 2022 1:37 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Preparing for Ketamine Tech FDA Pre-Investigational New Drug Package

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is collaborating with Premier Consulting to prepare a pre-investigational new drug (“IND”) package and meeting request with the United States Food and Drug Administration (FDA) for SPC-26, the company’s novel topical formulation of ketamine for the treatment of fibromyalgia. The company is planning to pursue a 505(b)(2) regulatory pathway for novel topical formulation of ketamine. According to the company, Premier Consulting will assist with the development of SILO’s nonclinical, clinical, clinical pharmacology, and biopharmaceutics strategy and program to be proposed to the FDA.…

MondayOct 03, 2022 1:28 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) K5 ASR to Enhance Security at Orange County Convention Center

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced a partnership with the award-winning, Orlando, Florida-based Orange County Convention Center (“OCCC” or the “Center”). A leader in creating safe, memorable experiences for visitors from around the world, the OCCC will begin utilizing Knightscope’s K5 Autonomous Security Robot (“ASR”) to enhance security and operational efficiency at the massive facility. According to the announcement, this represents Knightscope’s first-ever convention center contract and marks the company’s entrance into this area of the security market. “We are thrilled that Knightscope and the OCCC developed this…

MondayOct 03, 2022 12:55 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Poised to Bring ‘Potentially Impactful’ Therapy to GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a preclinical stage biotechnology company specializing in developing novel treatments for brain tumors, has focused on its lead drug candidate, Berubicin, to potentially treat glioblastoma (“GBM”). “CNS has since made significant headway, even receiving FDA Fast Track Designation, which now offers it an accelerated path to approval for Berubicin. ‘With this designation, we now have an accelerated pathway to approval for Berubicin and a clear opportunity to more expediently bring this potentially impactful investigational therapy to individuals battling this challenging disease,’ noted CNS CEO John Climaco. GBM’s median survival from initial diagnosis is less than 15…

MondayOct 03, 2022 12:15 pm

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Poised to Expand its Visibility and Diversify Investor base; Uplists on OTCQX(R) Best Market

EverGen Infrastructure Corp. announces upgrade from OTCQB(R) Venture Market to OTCQX market in US; Company's common shares to be quoted under "EVGIF" symbol OTCQX listing provides EverGen increased visibility and access to broader investor audience as company gears up to continue to execute on its ambitious growth plans This move comes amid favorable market conditions; global waste-to-energy market is projected to grow at a CAGR of 15.62% and reach USD 103.95 billion by 2027 As renewable natural gas (“RNG”) rapidly transforms from niche fuel to mainstream replacement for conventional natural gas, opportunities open up in the sector and EverGen Infrastructure…

MondayOct 03, 2022 12:05 pm

QualityStocksNewsBreaks – Why Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Is ‘One to Watch’

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties. “The company has an option to acquire a 99% interest in the Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia,” reads a recent article discussing the highly prospective Iska Iska, a road-accessible, royalty-free property. The piece highlights the company’s strong management and technical team working diligently to uncover the value of Iska Iska as well as another Peru-based project with good…

MondayOct 03, 2022 11:30 am

D-Wave Quantum Inc. (NYSE: QBTS) Offers Quantum Computing Solutions to Help Enterprises Solve Optimization Business Challenges, Today

40% of large enterprises are already experimenting with quantum computing to solve some of their most complex problems, according to 451 Research Optimization problems make up a significant portion of the enterprise problem universe, and annealing quantum computers are uniquely effective at solving these types of problems D-Wave is the only provider building both annealing and gate-model quantum computers that provide opportunities for businesses looking to optimize at scale The classical computer architecture relies on binary coding, which assigns values of 0 or 1, limiting the decision-making process to a return result of one. The binary space cannot handle large…

MondayOct 03, 2022 10:45 am

HeartBeam Inc. (NASDAQ: BEAT) Receives US Patent for Exclusive ECG Patch Monitor Designed to Detect Heart Issues

The USPTO issued a patent for BEAT’s 12-lead electrocardiogram (“ECG”) patch monitor for detection of ACS and cardiac arrhythmia HeartBeam has developed the only 3D-vector ECG platform for heart-attack detection anytime, anywhere BEAT’s patch technology could have a disruptive effect on the ECG patch market with its ischemia detection capability News about heart attacks and other life-threatening cardiovascular issues is alarming. Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States (https://ibn.fm/FN4BR), and recent reports suggest that COVID-19 may cause heart problems (https://ibn.fm/7QAky) and that the incidence of heart…

Site Search

Company Search

Month: October 2022